Axillary Hyperhidrosis Drug Market Report

Global and Region Axillary Hyperhidrosis Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：159
  • REPORT CODE：GMM911514
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Axillary Hyperhidrosis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Axillary Hyperhidrosis Drugmarket, defines the market attractiveness level of Axillary Hyperhidrosis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Axillary Hyperhidrosis Drug industry, describes the types of Axillary Hyperhidrosis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Axillary Hyperhidrosis Drug market and the development prospects and opportunities of Axillary Hyperhidrosis Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Axillary Hyperhidrosis Drug market in Chapter 13.

    By Player:

    • Dermira Inc

    • Allergan Plc

    • GlaxoSmithKline Plc

    • Dr August Wolff GmbH & Co KG Arzneimittle

    • TheraVida Inc

    • Brickell Biotech Inc

    By Type:

    • Botulinum ToxinA

    • Glycopyrrolate

    • Glycopyrronium Tosylate

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Home Care

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Axillary Hyperhidrosis Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Axillary Hyperhidrosis Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Axillary Hyperhidrosis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Axillary Hyperhidrosis Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Axillary Hyperhidrosis Drug Market Analysis and Outlook to 2022

    • 7.1 Global Axillary Hyperhidrosis Drug Consumption (2017-2022)

    • 7.2 United States Axillary Hyperhidrosis Drug Consumption (2017-2022)

    • 7.3 Europe Axillary Hyperhidrosis Drug Consumption (2017-2022)

    • 7.4 China Axillary Hyperhidrosis Drug Consumption (2017-2022)

    • 7.5 Japan Axillary Hyperhidrosis Drug Consumption (2017-2022)

    • 7.6 India Axillary Hyperhidrosis Drug Consumption (2017-2022)

    • 7.7 South Korea Axillary Hyperhidrosis Drug Consumption (2017-2022)

    8 Region and Country-wise Axillary Hyperhidrosis Drug Market Analysis and Outlook to 2028

    • 8.1 Global Axillary Hyperhidrosis Drug Consumption Forecast (2022-2028)

    • 8.2 United States Axillary Hyperhidrosis Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Axillary Hyperhidrosis Drug Consumption Forecast (2022-2028)

    • 8.4 China Axillary Hyperhidrosis Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Axillary Hyperhidrosis Drug Consumption Forecast (2022-2028)

    • 8.6 India Axillary Hyperhidrosis Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Axillary Hyperhidrosis Drug Consumption Forecast (2022-2028)

    9 Global Axillary Hyperhidrosis Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Axillary Hyperhidrosis Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Botulinum ToxinA Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Glycopyrrolate Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Glycopyrronium Tosylate Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Axillary Hyperhidrosis Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)

    10 Global Axillary Hyperhidrosis Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Axillary Hyperhidrosis Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Botulinum ToxinA Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Glycopyrrolate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Glycopyrronium Tosylate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Axillary Hyperhidrosis Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)

    11 Global Axillary Hyperhidrosis Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Axillary Hyperhidrosis Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Axillary Hyperhidrosis Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Axillary Hyperhidrosis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Axillary Hyperhidrosis Drug Market Competitive Analysis

    • 14.1 Dermira Inc

      • 14.1.1 Dermira Inc Company Details

      • 14.1.2 Dermira Inc Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Dermira Inc Axillary Hyperhidrosis Drug Product and Service

    • 14.2 Allergan Plc

      • 14.2.1 Allergan Plc Company Details

      • 14.2.2 Allergan Plc Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Allergan Plc Axillary Hyperhidrosis Drug Product and Service

    • 14.3 GlaxoSmithKline Plc

      • 14.3.1 GlaxoSmithKline Plc Company Details

      • 14.3.2 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product and Service

    • 14.4 Dr August Wolff GmbH & Co KG Arzneimittle

      • 14.4.1 Dr August Wolff GmbH & Co KG Arzneimittle Company Details

      • 14.4.2 Dr August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Dr August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product and Service

    • 14.5 TheraVida Inc

      • 14.5.1 TheraVida Inc Company Details

      • 14.5.2 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 TheraVida Inc Axillary Hyperhidrosis Drug Product and Service

    • 14.6 Brickell Biotech Inc

      • 14.6.1 Brickell Biotech Inc Company Details

      • 14.6.2 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Axillary Hyperhidrosis Drug

    • Figure Axillary Hyperhidrosis Drug Picture

    • Table Global Axillary Hyperhidrosis Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Axillary Hyperhidrosis Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Axillary Hyperhidrosis Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Axillary Hyperhidrosis Drug Consumption by Country (2017-2022)

    • Figure United States Axillary Hyperhidrosis Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Axillary Hyperhidrosis Drug Consumption and Growth Rate (2017-2022)

    • Figure China Axillary Hyperhidrosis Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Axillary Hyperhidrosis Drug Consumption and Growth Rate (2017-2022)

    • Figure India Axillary Hyperhidrosis Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Axillary Hyperhidrosis Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Axillary Hyperhidrosis Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Axillary Hyperhidrosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Axillary Hyperhidrosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Axillary Hyperhidrosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Axillary Hyperhidrosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Axillary Hyperhidrosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Axillary Hyperhidrosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Botulinum ToxinA Consumption and Growth Rate (2017-2022)

    • Figure Global Glycopyrrolate Consumption and Growth Rate (2017-2022)

    • Figure Global Glycopyrronium Tosylate Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Home Care Consumption and Growth Rate (2017-2022)

    • Figure Global Botulinum ToxinA Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glycopyrrolate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glycopyrronium Tosylate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Axillary Hyperhidrosis Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Axillary Hyperhidrosis Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Dermira Inc (Foundation Year, Company Profile and etc.)

    • Table Dermira Inc Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dermira Inc Axillary Hyperhidrosis Drug Product and Service

    • Table Allergan Plc (Foundation Year, Company Profile and etc.)

    • Table Allergan Plc Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Plc Axillary Hyperhidrosis Drug Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product and Service

    • Table Dr August Wolff GmbH & Co KG Arzneimittle (Foundation Year, Company Profile and etc.)

    • Table Dr August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product and Service

    • Table TheraVida Inc (Foundation Year, Company Profile and etc.)

    • Table TheraVida Inc Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table TheraVida Inc Axillary Hyperhidrosis Drug Product and Service

    • Table Brickell Biotech Inc (Foundation Year, Company Profile and etc.)

    • Table Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Brickell Biotech Inc Axillary Hyperhidrosis Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US